CurrentEndo
Get Weekly

Topic · page 28 of 35

Osteoporosis, bone & mineral

Osteoporosis in women and men, fracture risk and bone density, fragility fractures and their secondary prevention, bone drugs and treatment sequence; hyperparathyroidism and hypoparathyroidism, vitamin D, calcium and phosphate disorders, rare metabolic bone disease

Briefs 1,081–1,120 of 1,367 placed here, newest publication first

Briefs in Osteoporosis, bone & mineral

Newest publication first

  1. Osteoporos Int

    Associations of dietary oxidative balance score with femur osteoporosis in postmenopausal women: data from the National Health and Nutrition Examination Survey

    Cross-sectional study

  2. J Bone Miner Res

    Fracture Risk in Patients with Anorexia Nervosa Over a 40-Year Period

    Cohort study

  3. J Bone Miner Res

    Vitamin D Metabolites Are Associated With Musculoskeletal Injury in Young Adults: A Prospective Cohort Study

    Cohort study

  4. Osteoporos Int

    MRI-based vertebral bone quality score: relationship with age and reproducibility

    Cohort study

  5. J Clin Endocrinol Metab

    Vitamin D Binding Protein and Postsurgical Outcomes and Tissue Injury Markers After Hip Fracture: A Prospective Study

    Secondary analysis

  6. J Clin Endocrinol Metab

    Accelerated Bone Loss in Older Men With Severe Abdominal Aortic Calcification—the Prospective MINOS Study

    Cohort study

  7. J Bone Miner Res

    A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model

    Diagnostic or prognostic study

  8. J Clin Endocrinol Metab

    Risk Factors Associated with Incident Vertebral Fractures in Steroid-treated Males with Duchenne Muscular Dystrophy

    Cohort study

  9. Osteoporos Int

    Women’s perspectives regarding osteoporosis, fracture risk, and pharmacologic treatment: a cross-sectional study

    Cross-sectional study

  10. Osteoporos Int

    Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective

    Cohort study

  11. Osteoporos Int

    Romosozumab is associated with greater trabecular bone score improvement compared to denosumab in postmenopausal osteoporosis

    Cohort study

  12. Osteoporos Int

    A real-world pharmacovigilance study of abaloparatide based on the FDA Adverse Event Reporting System (FAERS)

    Cohort study

  13. Eur J Endocrinol

    The dose-dependent effect of estrogen on bone mineral density in trans girls

    Cohort study

  14. J Clin Endocrinol Metab

    Serum Klotho Modifies the Associations of 25-Hydroxy Vitamin D With All-Cause and Cardiovascular Mortality

    Cohort study

  15. Osteoporos Int

    Does vertebral osteoporosis delay or accelerate lumbar disc degeneration? A systematic review

    Meta-analysis

  16. J Bone Miner Res

    A Population-Based Registry Study of Extended Bisphosphonate Use: Minimal Shift After Landmark Publications About Shorter Treatment Duration

    Cohort study

  17. Osteoporos Int

    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX

    Meta-analysis

  18. Osteoporos Int

    Milk intake and hip fracture incidence in community-dwelling old Icelandic adults

    Cohort study

  19. Osteoporos Int

    Age- and dose-dependent effect of statin use on the risk of osteoporotic fracture in older adults

    Cohort study

  20. Osteoporos Int

    Clinical and biological parameters associated with fracture recurrence according to fracture liaison service dataset

    Cohort study

  21. J Bone Miner Res

    3D Finite Element Models Reconstructed From 2D Dual‐Energy X‐Ray Absorptiometry (DXA) Images Improve Hip Fracture Prediction Compared to Areal BMD in Osteoporotic Fractures in Men (MrOS) Sweden Cohort

    Diagnostic or prognostic study

  22. J Bone Miner Res

    Association Between Sarcopenia and Fracture Risk in a Population From the UK Biobank Database

    Cohort study

  23. Endocr Pract

    Cost Analysis of a Fracture Liaison Service: A Randomized Controlled Trial for the Secondary Prevention After Fragility Fractures of the Hip

    Randomized controlled trial

  24. Osteoporos Int

    The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study

    Cross-sectional study

  25. J Bone Miner Res

    No Effect of NSAID Use on Efficacy of Zoledronate: A Post Hoc Analysis of a Randomized Trial in Osteopenic Older Women

    Secondary analysis

  26. J Bone Miner Res

    Using Artificial Intelligence to Diagnose Osteoporotic Vertebral Fractures on Plain Radiographs

    Diagnostic or prognostic study

  27. J Clin Endocrinol Metab

    Treatment Persistence and Medication Switch Associated With Subsequent Fractures After Osteoporotic Fractures

    Cohort study

  28. Osteoporos Int

    The skeletal safety of milk-derived proteins: A meta-analysis of randomized controlled trials

    Meta-analysis

  29. JAMA Netw Open

    Adjusting FRAX Estimates of Fracture Probability Based on a Positive Vertebral Fracture Assessment

    Diagnostic or prognostic study

  30. J Bone Miner Res

    Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single‐center study

    Cross-sectional study

  31. Osteoporos Int

    A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank

    Cohort study

  32. J Clin Endocrinol Metab

    Efficacy and Safety of Burosumab in X-linked Hypophosphatemia

    Meta-analysis

  33. J Bone Miner Res

    Efficacy and Safety of Transdermal Abaloparatide in Postmenopausal Women with Osteoporosis: A Randomized Study

    Randomized controlled trial

  34. J Bone Miner Res

    Evaluation of the Effect of Sodium-Glucose Cotransporter 2 Inhibition on Fracture Risk: Evidence From Mendelian Randomization and Genetic Association Study

    Research article

  35. Osteoporos Int

    A genome-wide genomic score added to standard recommended stratification tools does not improve the identification of patients with very low bone mineral density

    Diagnostic or prognostic study

  36. Osteoporos Int

    Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

    Cohort study

  37. J Clin Endocrinol Metab

    Liver Fat, Bone Marrow Adipose Tissue, and Bone Mineral Density in Children With Overweight

    Cross-sectional study

  38. J Bone Miner Res

    Biochemical Markers of Calcium and Bone Metabolism during and after Lactation in Ugandan Women with HIV on Universal Maternal Antiretroviral Therapy

    Cohort study

  39. Eur J Endocrinol

    Nonsurgical hypoparathyroidism is associated with skeletal muscle dysfunction and restrictive lung disease

    Case-control study

  40. Osteoporos Int

    Drug adherence and treatment duration for denosumab and mortality risk among hip fracture patients

    Cohort study

All 1,367 Briefs in ExploreShowing Briefs 1,081–1,120 of 1,367, newest first